Literature DB >> 25700005

Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen.

Bridget A Hearon1, Casey L Pierce, Thröstur Björgvinsson, Garrett M Fitzmaurice, Shelly F Greenfield, Roger D Weiss, Alisa B Busch.   

Abstract

BACKGROUND: Co-occurring drug use disorders are under-detected in psychiatrically ill populations highlighting the need for more efficient screening tools.
OBJECTIVES: This study compares a single-item screening tool, previously validated in a primary care setting, to the 10-item Drug Abuse Screening Test (DAST-10) for identifying co-occurring drug use disorders among patients with severe psychiatric illness.
METHODS: A total of 395 patients attending a psychiatric partial hospital program completed both the single-item screen and DAST-10. A subsample of consecutive patients (n = 67) was also administered the Structure Clinical Interview for DSM-IV (SCID-IV) as a diagnostic reference standard.
RESULTS: Concordance between screening measures was moderate (κ = 0.4, p < 0.01). Sensitivity and specificity of the single-item screen and DAST-10 as compared to the SCID-IV were comparable, while area under the receiver operating curve showed better discriminatory power for the identification of drug use disorders with the single-item screen.
CONCLUSIONS: In comparison to the DAST-10, the single-item screen appears to be a more efficient tool to identify co-occurring drug use disorders in a psychiatric treatment setting among patients with a range of psychiatric diagnoses.

Entities:  

Keywords:  Assessment; co-occurring substance use disorders; dual diagnosis; psychiatric treatment; questionnaire; screening

Mesh:

Year:  2015        PMID: 25700005     DOI: 10.3109/00952990.2015.1005309

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  5 in total

1.  Acute Phase Treatment Outcomes of Electroconvulsive Therapy in Adolescents and Young Adults.

Authors:  Nicole M Benson; Stephen J Seiner; Paula Bolton; Garrett Fitzmaurice; Robert C Meisner; Casey Pierce; Alisa B Busch
Journal:  J ECT       Date:  2019-09       Impact factor: 3.635

Review 2.  Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease.

Authors:  Rachel L Bachrach; Shari S Rogal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-05-23

3.  Benzodiazepine misuse among adults receiving psychiatric treatment.

Authors:  R Kathryn McHugh; Andrew D Peckham; Thröstur Björgvinsson; Francesca M Korte; Courtney Beard
Journal:  J Psychiatr Res       Date:  2020-05-24       Impact factor: 4.791

4.  Referral to Treatment After Positive Screens for Unhealthy Drug Use in an Outpatient Veterans Administration Setting.

Authors:  Dominic Hodgkin; Wenwu Gao; Mary Jo Larson; Charles E Drebing; Elizabeth L Merrick; Marianne Pugatch; Constance M Horgan; Galina Zolotusky; Nancy M Petry; Richard Saitz
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

5.  Delivering Remote Measurement-Based Care in Community Addiction Treatment: Engagement and Usability Over a 6-Month Clinical Pilot.

Authors:  Kevin A Hallgren; Eliza B Cohn; Richard K Ries; David C Atkins
Journal:  Front Psychiatry       Date:  2022-04-07       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.